Role of p53 mutation in the effect of boron neutron capture therapy on oral squamous cell carcinoma

por Fujita, Yusei, Kato, Itsuro, Iwai, Soichi, Ono, Koji, Suzuki, Minoru, Sakurai, Yoshinori, Ohnishi, Ken, Ohnishi, Takeo, Yura, Yoshiaki
Publicado 2009

Sonoporation as an enhancing method for boron neutron capture therapy for squamous cell carcinomas

por Yamatomo, Naofumi, Iwagami, Takaki, Kato, Itsuro, Masunaga, Shin-Ichiro, Sakurai, Yoshinori, Iwai, Soichi, Nakazawa, Mitsuhiro, Ono, Koji, Yura, Yoshiaki
Publicado 2013

Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB(0,+), LAT1 and LAT2

por Wongthai, Printip, Hagiwara, Kohei, Miyoshi, Yurika, Wiriyasermkul, Pattama, Wei, Ling, Ohgaki, Ryuichi, Kato, Itsuro, Hamase, Kenji, Nagamori, Shushi, Kanai, Yoshikatsu
Publicado 2015

Early clinical experience utilizing scintillator with optical fiber (SOF) detector in clinical boron neutron capture therapy: its issues and solutions

por Ishikawa, Masayori, Yamamoto, Tetsuya, Matsumura, Akira, Hiratsuka, Junichi, Miyatake, Shin-Ichi, Kato, Itsuro, Sakurai, Yoshinori, Kumada, Hiroaki, Shrestha, Shubhechha J., Ono, Koji
Publicado 2016

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

por Barth, Rolf F, H Vicente, M Graca, Harling, Otto K, Kiger, WS, Riley, Kent J, Binns, Peter J, Wagner, Franz M, Suzuki, Minoru, Aihara, Teruhito, Kato, Itsuro, Kawabata, Shinji
Publicado 2012